Oncolytics Biotech Inc (ONCY) stock
ONCYNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.38+0.04 (+12.53%)
Close on Nov 17, 2026Market cap $48.77MP/E –Yield –
Oncolytics Biotech enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Oncolytics Biotech's enterprise value was $44.46M on Nov 11, 2026, against $68.36M a year earlier. Over the last 5 years it ranged from $15.61M to $142.06M, with a median of $56.73M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $44.46M | -23.8% |
| 2025 | Dec 31, 2025 | $58.31M | +55.3% |
| 2024 | Dec 31, 2024 | $37.55M | -46.0% |
| 2023 | Dec 29, 2023 | $69.50M | +22.5% |
| 2022 | Dec 30, 2022 | $56.73M | +79.3% |
| 2021 | Dec 31, 2021 | $31.64M | -23.9% |
| 2020 | Dec 31, 2020 | $41.59M | -36.7% |
| 2019 | Dec 31, 2019 | $65.67M | +296.8% |
| 2018 | Dec 31, 2018 | $16.55M | -71.7% |
| 2017 | Dec 29, 2017 | $58.49M | +963.0% |
| 2016 | Dec 30, 2016 | $5.50M | – |
See a number that looks wrong?